RCM Technologies (RCMT) risk factors, FY2024 10-K

RCM Technologies's FY2024 10-K, filed Mar 13, 2025, lists 91 risk factors. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
910 groups
Section length
28k wordsItem 1A

RCM Technologies's biggest risks in the FY2024 10-K

  • RCM Technologies faces economic cyclicality impacting its engineering and healthcare staffing segments.
  • Client disputes over engineering designs create potential liabilities up to $3.3 million.
  • Internal control weaknesses in information technology remain a risk area.

The risks most specific to RCM Technologies

  • RCM participates in a market that is cyclical in nature and sensitive to economic changes. As a result, the impact of economic changes on revenue and operations can be substantial, resulting in significant volatility in the Company’s financial performance

    RCM participates in a cyclical market sensitive to economic changes, causing significant volatility in financial performance.

  • Forward-looking Information

    Customer capital spending slowdowns in the U.S. or Canada can adversely impact engineering and life sciences demand.

  • Commitments and Contingencies (Continued)

    An engineering client alleged a partially designed system is flawed, exposing RCM to potential liabilities capped at $3.3 million.

  • Consulting, staffing, and project services are generally priced based on mark-ups on prevailing rates of pay, and as a result are able to generally maintain their relationship to direct labor costs. Permanent placement services are priced as a function of salary levels of the job candidates

    Rising healthcare benefit costs in a labor-intensive business cannot always be fully passed on to customers.

  • Changes in Internal Control over Financial Reporting

    Management identified a material weakness in internal controls related to information technology design and maintenance.

All 91 risk factors

Headings as the filing states them, in filing order.

Other

  1. 01RCM participates in a market that is cyclical in nature and sensitive to economic changes. As a result, the impact of economic changes on revenue and operations can be substantial, resulting in significant volatility in the Company’s financial performance
  2. 02Critical Accounting Policies and Use of Estimates
  3. 03Revenue Recognition (Continued)
  4. 04Permanent Placement Services
  5. 05Accounts Receivable and Provision for Credit Losses
  6. 06Long-Lived and Intangible Assets
  7. 07Accounting for Restricted Stock Awards
  8. 08Accounting for Income Taxes
  9. 09Performance-Based Restricted Stock and Stock Unit Awards
  10. 10Forward-looking Information
  11. 11Fiscal Year Ended December 28, 2024 Compared to Fiscal Year Ended December 30, 2023
  12. 12The Company follows a 52/53 week fiscal reporting calendar ending on the Saturday closest to December 31. The fiscal years ended December 28, 2024 (fiscal 2024) and December 30, 2023 (fiscal 2023) consisted of fifty-two weeks each
  13. 13Fiscal Year Ended December 28, 2024 Compared to Fiscal Year Ended December 30, 2023 (Continued)
  14. 14Life Sciences, Data and Solutions
  15. 15Supplemental Operating Results on a Non-GAAP Basis
  16. 16The following table summarizes the major captions from the Company’s Consolidated Statements of Cash Flows
  17. 17Operating Activities (Continued)
  18. 18An increase in accounts payable and accrued expenses provided cash of $1.1 million for the fiscal year ended December 28, 2024 as compared to using $1.5 million for the comparable prior year period. The Company attributes these changes to typical fluctuations in the normal course of business
  19. 19interest rate, including unused line fees, for the fiscal years ended December 28, 2024 and December 30, 2023 was 6.6% and 6.5%, respectively
  20. 20Current Liquidity and Revolving Credit Facility
  21. 21Current Liquidity and Revolving Credit Facility (Continued)
  22. 22All restricted share awards contain a dividend equivalent provision entitling holders to dividends paid between the restricted stock award grant date and ultimate share distribution date. As of December 28, 2024, there were no accrued dividends
  23. 23Commitments and Contingencies
  24. 24Commitments and Contingencies (Continued)
  25. 25The Company leases office facilities and various equipment under non-cancelable leases expiring at various dates through October 2029. Certain leases are subject to escalation clauses based upon changes in various factors
  26. 26Future Contingent Payments
  27. 27Consulting, staffing, and project services are generally priced based on mark-ups on prevailing rates of pay, and as a result are able to generally maintain their relationship to direct labor costs. Permanent placement services are priced as a function of salary levels of the job candidates
  28. 28ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
  29. 29ITEM 9A. CONTROLS AND PROCEDURES
  30. 30Evaluation of Disclosure Controls and Procedures
  31. 31Changes in Internal Control over Financial Reporting
  32. 32Management’s Annual Report on Internal Control over Financial Reporting
  33. 33Management’s Annual Report on Internal Control over Financial Reporting (Continued)
  34. 34On March 12, 2025, the Company and Mr. Vizi entered into an amendment and restatement of his Executive Severance Agreement dated June 1, 2018, which was filed as an exhibit to the Company’s Current Report on Form 8-K dated June 7, 2018 (the "Severance Agreement")
  35. 35the multiplier applicable to the amount that Mr. Vizi would receive, if a Change in Control occurs and he experiences a qualifying termination, from 2.0 times, as set forth in the original Severance Agreement, to 2.99 times, with the definition of Bonus for the purpose of such calculation modified as described above
  36. 36(b) Rule 10b5-1 Trading Plans
  37. 37(1) The aggregate number of shares that can be sold under the plan is allocated into a series of tranches that would be sold at laddered prices as outlined in the plan
  38. 38The information required by Item 10 shall be included in the 2025 Proxy Statement and is incorporated herein by reference
  39. 39Except as set forth below, the information required by Item 12 shall be included in the 2025 Proxy Statement and is incorporated herein by reference
  40. 40The following exhibits are filed as part of, or incorporated by reference into, this report (unless otherwise
  41. 41Chief Financial Officer, Treasurer and Secretary
  42. 42Opinion on the Financial Statements
  43. 43Description of the Matter
  44. 44We have audited RCM Technologies, Inc. and Subsidiaries’ (the “Company”) internal control over financial reporting as of December 28, 2024, based on the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”)
  45. 45We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects
  46. 46Definition and Limitations of Internal Control Over Financial Reporting
  47. 47Deferred income taxes, net, foreign
  48. 48Contingent consideration from acquisitions, net of current position
  49. 49Contingencies (note 16) and Commitments (note 18)
  50. 50with exercises of equity awards
  51. 51Purchase of treasury stock
  52. 52Adjustments to reconcile net income (loss) to net cash provided by
  53. 53Effect of excess tax deduction on equity awards
  54. 54Proceeds from sale of assets
  55. 55Contingent consideration paid
  56. 56Description of Business and Basis of Presentation
  57. 57Cash and Cash Equivalents
  58. 58Fair Value of Financial Instruments
  59. 59Unbilled Accounts Receivable and Work-in-Process
  60. 60Transit Accounts Receivable and Transit Accounts Payable
  61. 61Permanent placement revenue was $1.5 million and $1.7 million for the fiscal years ended December 28, 2024 and December 30, 2023, respectively
  62. 62Transit Receivables and Transit Payables
  63. 63Foreign Currency Translation
  64. 64Share - Based Compensation
  65. 65Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs
  66. 66Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs
  67. 67USE OF ESTIMATES AND UNCERTAINTIES
  68. 685. PROPERTY AND EQUIPMENT
  69. 696. ACQUISITIONS AND DIVESTITURES
  70. 70Potential future contingent payments to be made to all active acquisitions after December 28, 2024 are capped at a cumulative maximum of $0.2 million
  71. 716. ACQUISITIONS AND DIVESTITURES (CONTINUED)
  72. 72Impairment in fiscal 2024
  73. 739. LINE OF CREDIT (CONTINUED)
  74. 74For the fiscal years ended December 28, 2024 and December 30, 2023, there were no anti-dilutive shares included in the calculation of common stock equivalents as there were no stock options outstanding
  75. 75At December 28, 2024, the Company had two share-based employee compensation plans, the Employee Stock Purchase Plan and the 2014 Omnibus Equity Compensation Plan
  76. 76Employee Stock Purchase Plan
  77. 77Employee Stock Purchase Plan (Continued)
  78. 782014 Omnibus Equity Compensation Plan (the 2014 Plan)
  79. 79As of December 28, 2024, under the 2014 Plan, 289,421 time-based shares were outstanding, 300,000 performance-based restricted stock awards were outstanding and 295,680 shares were available for awards thereunder
  80. 80Time-Based Restricted Stock Awards
  81. 81From time-to-time the Company issues performance-based restricted stock awards to its employees. Performance-based restricted stock awards are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee
  82. 82Share-based compensation for performance-based equity agreement was $1.6 million and $0.7 million for the fiscal years ended December 28, 2024 and December 30, 2023, respectively
  83. 8312. TREASURY STOCK TRANSACTIONS
  84. 84On April 24, 2023, the Company agreed to repurchase, in a private transaction approved by the Board, 333,686 shares of common stock at a per-share price of $11.91 per share
  85. 8513. NEW ACCOUNTING STANDARDS
  86. 86Remeasurement of contingent consideration
  87. 87$ 141 $ 724 $ 123 $ 1,943 $ 2,931
  88. 8814. SEGMENT INFORMATION (CONTINUED)
  89. 8915. INCOME TAXES (CONTINUED)
  90. 90The Company accounts for penalties or interest related to uncertain tax positions as part of its provision for income taxes and records such amounts to tax expense. The Company recorded no expense for penalties or interest in the fiscal years ended December 28, 2024 and December 30, 2023
  91. 91Deferred tax liability, net, Canada

Other RCM Technologies 10-Ks

  • FY2025 10-K risk factors
    86 risks32 new37 dropped48 reworded

    RCM Technologies faces material weaknesses in internal controls requiring comprehensive remediation.

    Filed Apr 03, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.